The government is looking forward to the early launch of the single-dose Kovid-19 vaccine Sputnik Lite in India and directs all stakeholders, including the Russian manufacturer and its Indian partners, to fast-track application and regulatory approval processes for the jab. Promote the country’s vaccination campaign, sources said on Thursday. An application seeking regulatory approval for Sputnik Lite is expected to be filed within the next few weeks and could become the first single-dose vaccine to be launched in India, sources said, adding that high-level discussion among top government officials Citing said. To promote domestic availability of Kovid-19 vaccines in recent times.
In a meeting chaired by the Cabinet Secretary last week, it was suggested to call a meeting immediately with all concerned stakeholders including the Secretary of the Department of Biotechnology, Drugs Controller General of India (DCGI), representatives of the Ministry of External Affairs, the Union Department of Health. Ministry officials, RDIF (Russian Direct Investment Fund) and to speed up regulatory approvals for domestic manufacturer Sputnik Lite. In the meeting on Sputnik Light, it was discussed that Russia has already approved this vaccine and its trials are going on in other countries. The Drug Controller of India (DCGI) informed other participants that applications for regulatory approval of Sputnik Lite are expected to be filed within the next 2-3 weeks. With inputs from PTI.
More Stories
Due to India’s growing stature in the world, why China-Pak got chilli
Mamata’s new Bengal becomes the new launch pad of terrorism
Small farmers are the real power of the dairy sector, an example for the world, India’s network of dairy cooperatives: PM Modi